Local News: Seattle, WA 

 | 

Sign Up

 | 

Sign In

Multiple Sclerosis News Editors

News Widget

Display the Multiple Sclerosis news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Multiple Sclerosis News

News on Multiple Sclerosis continually updated from thousands of sources around the net.

59 min ago | Herald Gazette

New, emerging multiple sclerosis treatments topic of June 6 talk

The June meeting of Keep S'myelin will be held Thursday, June 6, 11:30 a.m. at Kno-Wal-Lin Home Care and Hospice at 170 Pleasant St.

Comment?

Related Topix: Medicine, Health

5 hrs ago | Bloomberg

MS Patients Choose Death Risk With Potent Drug Treatment

Kari Antin, a 40-year-old financial analyst in Minneapolis, knows she's taking a life-or-death risk with every monthly infusion of Biogen Idec Inc.'s Tysabri.

Comment?

Related Topix: Health, Weston, MA

5 hrs ago | The Moultrie News

High winds couldna t keep walkers away from Walk MS

Walk More than 100 people came together at Edwards Park for this year's Walk MS: Charleston on May 4. The Greater Carolinas Chapter of the National Multiple Sclerosis Society is excited to announce more than 100 people came together at Edwards Park for this year's Walk MS: Charleston on May 4. Walk MS, presented by Biogen Idec, is an opportunity ... (more)

Comment?

Related Topix: Weather, Charleston, SC, Medicine, Health, National Multiple Sclerosis Society, Charitable Organizations

6 hrs ago | Swindon Advertiser

The smurf team take part in the MS Challenge in Snowdonia

SWINDON Therapy Centre is encouraging people to take part in the MS Challenge 2013 to help raise money for the centre.

Comment?

Related Topix: Medicine, Health

8 hrs ago | Bioscience Technology

Biogen submits new MS drug for FDA approval

Specialty drugmaker Biogen Idec said Tuesday it submitted a new injectable multiple sclerosis drug to the Food and Drug Administration for U.S. market approval.

Comment?

Related Topix: Food and Drug Administration, Biotech, Biogen Idec, Medicine, Health

12 hrs ago | Kamloops This Week

Monthly MS clinic on its way to Kamloops

By Dale Bass - Kamloops This Week Published: May 22, 2013 4:00 PM Updated: May 22, 2013 4:34 PM Kamloopsians being treated for multiple sclerosis will no longer have to leave the Tournament Capital as an outreach clinic will be opening in the city next month.

Comment?

Related Topix: Health

Wed May 22, 2013

Sunderland Echo

Cakes for Multiple Sclerosis in Sunderland shopping centre

The centre management team will be fund-raising on Friday, May 31, as part of the MS Society's Cake Break event.

Comment?

Related Topix: Medicine, Health

Vail Daily News

Beaver Creek golf tourney to benefit Can Do Multiple Sclerosis

Beaver Creek Resort Co. has selected Can Do MS as the beneficiary of its second annual Cut and Slice Golf Event presented by US Bank, to be held on Monday at the Beaver Creek Golf Club from 11:30 a.m. to 4 p.m. Golfers also will enjoy barbecue and craft beers from Crazy Mountain Brewery and Breckenridge Brewery around the course.

Comment?

Related Topix: Medicine, Health

ABC News

New grant to fund multiple sclerosis trials, research

A new Commonwealth grant for researching multiple sclerosis is expected to advance existing research collaborations and enable new ones.

Comment?

Related Topix: Medicine, Health

Business Journal

Express Scripts: Spending on specialty medications to grow 67 percent

Express Scripts expects spending on specialty medications in the U.S. to jump 67 percent by the end of 2015, according to a new company study released Tuesday.

Comment?

Related Topix: Medicine, Health, Rheumatoid Arthritis

Tue May 21, 2013

The Motley Fool

Another Multiple Sclerosis Winner for Biogen

In this video, health-care analyst David Williamson discusses Biogen's latest drug up for FDA approval.

Comment?

Related Topix: Medicine, Health, Healthcare Law, Law

BioMed Central

The clinical potential of blood-proteomics in multiple sclerosis

The aetiology of multiple sclerosis remains unknown. This hampers molecular diagnosis and the discovery of bio-molecular markers.

Comment?

Related Topix: Medicine, Health

P&T Community

Multiple Sclerosis Drug Plegridy (Peginterferon) Submitted for FDA Review

A biologics license application has been submitted to the FDA for approval of Plegridy , a pegylated subcutaneous injectable candidate for relapsing forms of multiple sclerosis .

Comment?

Related Topix: Healthcare Law, Law, Medicine, Health

Examiner.com

Biogen Idec's Plegridy with the FDA now

Plegridya is Biogen Idec's newly developed subcutaneously administered multiple sclerosis drug therapy and it as just been announced today that it has been submitted to the FDA for the okay to put on the market.

Comment?

Related Topix: Healthcare Law, Law, Medicine, Health, Lima, OH

Medical News Today

Researchers Able To Prevent And Cure Type 1 Diabetes In Animal Models

Main Category: Diabetes Also Included In: Immune System / Vaccines ; Multiple Sclerosis ; Arthritis / Rheumatology Article Date: 21 May 2013 - 1:00 PDT Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been ... (more)

Comment?

Related Topix: Medicine, Diabetes, Health, Rheumatology, Insulin (generic), Humulin, Novolin, Immunology, Biology, Science

P&T Community

Multiple Sclerosis Drug Fails Phase III Trial

A pivotal phase III study of arbaclofen placarbil for the treatment of patients with spasticity due to multiple sclerosis was unsuccessful in demonstrating that the drug provided statistically significant improvement compared with placebo in the trial's co-primary endpoints.

Comment?

Related Topix: Medicine, Health

Mon May 20, 2013

Examiner.com

5 unique and outside-the-box multiple sclerosis researched therapies

Multiple sclerosis , a neurological disease that affects millions of people all across the world, harms everyone who has this disease is such unbelievable ways and, as of yet, finding a cure has proved incredibly allusive.

Comment?

Related Topix: Medicine, Health

Reuters

XenoPort to drop multiple sclerosis drug after trial failure

XenoPort Inc said it will stop developing its experimental multiple sclerosis treatment after data from a late-stage trial showed the drug did not improve patients' condition significantly compared with a placebo.

Comment?

Related Topix: Startups, XenoPort, Medicine, Health

Sun May 19, 2013

The Motley Fool

Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Started

In this video, health-care analyst David Williamson discusses why Biogen Idec 's party may just be getting started despite a huge run in the stock already.

Comment?

Related Topix: Medicine, Health, Health Insurance

Daily Mail

'Only cannabis spray relieves my MS - so why won't the NHS give it to ...

'Only cannabis spray relieves my MS - so why won't the NHS give it to me?' Sufferer refused drug to help ease affects of disease Mr Rudd was refused Sativex on the NHS while sufferers living a few miles away are being prescribed the cannabis spray The drug hasn't been assessed by the National Institute for Health and Clinical Excellence - meaning ... (more)

Comment?

Related Topix: Health, Medicine, Neurology